Table 1 Patient characteristics
From: In myotonic dystrophy type 1 reduced FDG-uptake on FDG-PET is most severe in Brodmann area 8
Patient Number | Sex | Age symptom onset | Age at FDG-PET | CTG expansion | Diabetes (glucose level) |
|---|---|---|---|---|---|
1 | F | 58 (late onset) | 64 | 83 | No (<120 mg/dl) |
2 | M | 35 (late onset) | 74 | 100 | No (<120 mg/dl) |
3 | F | 45 (late onset) | 64 | 150 | Yes (120–160 mg/dl) |
4 | F | 32 (late onset) | 46 | 176 | No (<120 mg/dl) |
5 | F | 25 (late onset) | 41 | 230 | No (<120 mg/dl) |
6 | F | 30 (late onset) | 49 | 330 | No (<120 mg/dl) |
7 | M | 26 (late onset) | 36 | 400 | No (<120 mg/dl) |
8 | M | 30 (late onset) | 50 | 400 | Yes (120–160 mg/dl) |
9 | F | 19 (late onset) | 26 | 400 | No (<120 mg/dl) |
10 | F | 30 (late onset) | 49 | 400 | No (<120 mg/dl) |
11 | M | 40 (late onset) | 58 | 430 | No (<120 mg/dl) |
12 | F | 14 (early onset) | 34 | 660 | No (<120 mg/dl) |
13 | F | 13 (early onset) | 27 | 660 | No (<120 mg/dl) |
14 | F | 14 (early onset) | 31 | 670 | No (<120 mg/dl) |
15 | F | 28 (late onset) | 54 | 850 | Yes (120–160 mg/dl) |
16 | F | 39 (late onset) | 47 | 1000 | No (<120 mg/dl) |
17 | M | 40 (late onset) | 51 | 1168 | Yes (<120 mg/dl) |
18 | M | 24 (late onset) | 44 | 1300 | No (<120 mg/dl)c |
19 | F | 28 (late onset) | 50 | 1400 | No (<120 mg/dl) |
20 | M | 29 (late onset) | 46 | 1500 | No (<120 mg/dl) |
21 | F | 38 (late onset) | 58 | 1560 | No (<120 mg/dl) |
22 | M | 5 (early onset) | 41 | 1600 | No (<120 mg/dl) |
23 | M | 14 (early onset) | 55 | 1700 | Yes (<120 mg/dl) |
24 | F | 6 (early onset) | 26 | 2000 | Yes (<120 mg/dl) |